Role of spinal σ1 and σ2 opioid receptors in the antinociception produced by microinjection of L-glutamate in the ventromedial medulla of the rat

Document Type

Article

Publication Date

1997

Abstract

This study examined the contribution of spinal σ1 and σ2 opioid receptors to the antinociception produced by microinjection of L-glutamate in either the nucleus raphe magnus (NRM) or the nucleus reticularis gigantocellularis pars a (NGCpα) of the rat. Intrathecal (i.t.) pretreatment with 1 µg of 7-benzylidinenaltrexone (BNTX), a σ1 opioid receptor antagonist, did not antagonize the increase in tail flick latency (TFL) produced by microinjection of L-glutamate in either the NRM or the NOCpα. In contrast, i.t. pretreatment with 3 µg of naltriben (NTB), a σ2 opioid receptor antagonist, completely antagonized the increase in TFL evoked by microinjection of L-glutamate in the NRM, but did not antagonize the increase in TFL evoked from the NGCpα. These results suggest that the antinociception produced by activation of these bulbospinal pathways is predominantly mediated by spinal σ2 opioid receptors and that there is little, if any, contribution by spinal 61 opioid receptors.

Publication Title

Brain research

Volume

765

Issue

1

First Page

177

Last Page

181

Comments

This article was published in Brain research, Volume 765, Issue 1, Pages 177-181.

The published version is available at http://dx.doi.org/10.1016/S0006-8993(97)00658-6.

Copyright © 1997 Elsevier.

This document is currently not available here.

COinS